convalescent serum

High frequency of anti-DSG 2 antibodies in post COVID-19 serum samples

Evaluation of safety and immunogenicity of receptor-binding domain-based COVID-19 vaccine (Corbevax) to select the optimum formulation in open-label, multicentre, and randomised phase-1/2 and phase-2 clinical trials

Characterization of the SARS-CoV-2 B.1.621 (Mu) variant

SARS-CoV-2 B.1.621(Mu) 변종 특성화

Urtica dioica Agglutinin: A plant protein candidate for inhibition of SARS-COV-2 receptor-binding domain for control of Covid19 Infection

Urtica dioica Agglutinin: Covid19 감염 통제를 위한 SARS-COV-2 수용체 결합 도메인 억제를 위한 식물성 단백질 후보

Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone

Pre-Omicron 백신의 획기적인 감염은 단독 감염에 비해 SARS-CoV-2 Omicron BA.1에 대해 우수한 교차 중화를 유도합니다

Convalescent serum-derived exosomes: Attractive niche as COVID-19 diagnostic tool and vehicle for mRNA delivery

An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo

조작된 ACE2 미끼는 SARS-CoV-2 Omicron 변이체를 중화하고 생체 내 감염으로부터 보호합니다.

Phase 1/2 clinical trial of COVID-19 vaccine in Japanese participants: A report of interim findings

일본 참가자를 대상으로 한 코로나19 백신 임상 1/2상: 중간 결과 보고

High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infection

SARS-CoV-2 감염 회복 후 인간의 장기 혈청 항체에 대한 고해상도 분석

SARS-CoV-2 Omicron variant: recent progress and future perspectives

SARS-CoV-2 오미크론 변종: 최근 진행 상황 및 미래 전망